You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
16 June 2008
AngioGenex ernennt neuen CEO zur Leitung der Entwicklung von Anti-Krebs Medikamenten
23 January 2008
Benezra Report in Nature Biotechnology Validates AngioGenex’s Drug Development Platform by Demonstrating Tumor Suppression through
18 January 2008
Angiogenex Inc.: William Garland Joins AngioGenex’s New Board of Directors
17 October 2007
AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer
25 June 2007
AngioGenex European Listing Approved-Company’s Shares now Trading on the Frankfurt Stock Exchange under Symbol ‘TLE.’